Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BCTX
BCTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BCTX News
BriaCell Engages CRA and Kaleio for Market Access Evaluation of Bria-IMT
1d ago
Newsfilter
BriaCell Partners with Uneedle for Microneedle Technology in Cancer Treatment
Jun 26 2026
NASDAQ.COM
BriaCell Partners with Uneedle for Microneedle Technology in Cancer Treatment
Jun 25 2026
Newsfilter
BriaCell Reports Promising Phase 2 Data for Breast Cancer Treatment
Jun 01 2026
Newsfilter
BriaCell Therapeutics Prices 1.4 Million Share Best-Efforts Offering
Jun 01 2026
Yahoo Finance
BriaCell Therapeutics Prices Public Offering at $3.25 per Share
Jun 01 2026
NASDAQ.COM
BriaCell Announces Pricing of 1.45 Million Shares at $3.25 Each
Jun 01 2026
Newsfilter
BriaCell's Immunotherapy Study Receives Positive DSMB Recommendation
May 26 2026
NASDAQ.COM
BriaCell's Phase 3 Study Receives Sixth Positive DSMB Recommendation
May 26 2026
Newsfilter
BriaCell Reports Positive Clinical Data at ASCO 2026
May 22 2026
Newsfilter
BriaCell Expands Focus on Women's Health with New Ovarian Cancer Therapy
May 15 2026
Newsfilter
BriaCell Launches Next-Gen Immunotherapy for Prostate Cancer
May 14 2026
Newsfilter
BriaCell's Phase 3 Clinical Trial Shows Significant Progress
May 12 2026
Newsfilter
BriaCell Expands Clinical Trial Network with NYU Langone Health
May 07 2026
Newsfilter
BriaCell Receives FDA Clearance for Clinical Study of Bria-BRES+
May 06 2026
Newsfilter
BriaCell to Present Clinical Data at 2026 ASCO Annual Meeting
Apr 27 2026
Newsfilter
Show More News
